Jagsonpal Pharmaceuticals Ltd - 507789 - Reg. 34 (1) Annual Report
Notice of 42nd Annual General Meeting along with Annual Report for the Financial Year 2020-2021 is enclosed.07-09-2021
07-09-2021
Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of copies of newspaper advertisements regarding 42nd Annual General Meeting of the Company to be held on Thursday, September 30, 2021 through Video Conferencing/ Other Audio-Visual Means.07-09-2021
Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
In terms of regulation 30 of the SEBI (LODR) Regulations, 2015, please find enclosed herewith a copy of the Press Release on the Unaudited Financial results of the Company for the quarter ended 30th June, 2021.16-08-2021
Jagsonpal Pharmaceuticals Ltd - 507789 - Board Meeting Outcome for Outcome Of The Board Meeting.
Outcome of the Board Meeting for the approval of the unaudited results for the quarter ended 30 June, 2021. The board meeting was concluded at 1855 hours.13-08-2021
Jagsonpal Pharmaceuticals Ltd - 507789 - Outcome Of The Board Meeting Held On 13 August, 2021.
Outcome of the Board meeting held on 13 August, 2021. The meeting was concluded at 1855 hours.13-08-2021
Jagsonpal Pharmaceuticals Ltd - 507789 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended 30 June, 2021
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 ,inter alia, to consider and approve unaudited financial results for the quarter ended 30 June, 202104-08-2021
Jagsonpal Pharmaceuticals Ltd - 507789 - Disclosure Of Related Party Transaction Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements Regulations, (Amendments) 2018 For The Financial Year Ended 31 March, 2021.
Pursuant to Regulation 23 (9) of the SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2018, please find enclosed disclosure of Related Party Transaction, in the format specified in the Accounting Standard for the financial year ended March 31, 2021. This is for your information and records.29-07-2021
Jagsonpal Pharmaceuticals Ltd - 507789 - Shareholding for the Period Ended June 30, 2021
Jagsonpal Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here19-07-2021
Jagsonpal Pharmaceuticals Ltd - 507789 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- NANDITA SINGHDesignation :- Company Secretary and Compliance Officer14-07-2021
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Clarification On Price Movement.
Clarification On Price Movement.12-07-2021